Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
In this study, we will assess the change of serum ACE-2, angiotensin(1-7), and vascular
function after using olmesartan (an ARB), compared to conventional anti-hypertensive drug,
amlodipine in hypertensive patients with T2DM.